InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Kirk Christopher J.. Officer active across 1 company, notably Kezar Life Sciences, Inc.. Cumulatively, 2 reports have been published. Activity tracked since 23 June 2022. The latest transaction was disclosed on 20 July 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条